Everything below concerns Lyophilized powder. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-04-19. Where a claim depends on a specific study, the study is described rather than over-claimed.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | GHRH receptor agonist |
| Sequence length | 29 amino acids | Derived from human GHRH |
| Molecular weight | About 3368 Da without linker | Albumin-binding form is heavier |
| Appearance | White to off-white lyophilized powder | Common form for research reference material |
| Typical storage | -20 °C or below, desiccated | Protect powder from light and moisture |
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
Reconstitution is typically performed with sterile water or bacteriostatic water, added slowly against the vial wall. The resulting solution should be clear and colorless; cloudiness or visible particles suggest a problem with the material or the diluent. Once in solution, the peptide is less stable than the dry powder. Refrigerated storage at two to eight degrees Celsius is common for short-term holding, while freezing aliquots is described for longer periods.
Purity is most often assessed by reversed-phase high-performance liquid chromatography, reported as a percentage of total peak area. Identity is confirmed by mass spectrometry, which yields a molecular ion consistent with the expected sequence. Amino acid analysis and peptide mapping provide additional characterization. Reported purity values are method-dependent, so figures from different laboratories are not always directly comparable without details of column, gradient, and detection wavelength.
Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.
=== Toxicity === Acetonitrile has only modest toxicity in small doses. It can be metabolised to produce hydrogen cyanide, which is the source of the observed toxic effects. Generally the onset of toxic effects is delayed, due to the time required for the body to metabolize acetonitrile to cyanide (generally about 2–12 hours). Cases of acetonitrile poisoning in humans are rare but not unknown by inhalation and ingestion. The symptoms, which do not usually appear for several hours after the exposure, include breathing difficulties, slow pulse rate, nausea, and vomiting. Convulsions and coma can occur in serious cases, followed by death from respiratory failure. The treatment is as for cyanide poisoning, with oxygen, sodium nitrite, and sodium thiosulfate among the most commonly used emergency treatments. It has been used in a formulation for removal of sculptured fingernails. At least two cases have been reported of accidental poisoning of young children by acetonitrile-based sculptured nail remover, one of which was fatal. Acetone and ethyl acetate are often preferred as safer for domestic use, and acetonitrile has been banned in cosmetic products in the European Economic Area since March 2000.
=== Nonlinear curve fitting === Nonlinear curve-fitting programs, such as Equilibrium Binding Data Analysis (EBDA) and LIGAND, are used to calculate estimates of binding parameters from saturation and competition-binding experiments. EBDA performs the initial analysis, which converts measured radioactivity into molar concentrations and creates Hill slopes and Scatchard transformations from the data. The analysis made by EBDA can then be used by LIGAND to estimate a specified model for the binding.
== Clinical significance == AST is similar to alanine transaminase (ALT) in that both enzymes are associated with liver parenchymal cells. The difference is that ALT is found predominantly in the liver, with clinically negligible quantities found in the kidneys, heart, and skeletal muscle, while AST is found in the liver, heart (cardiac muscle), skeletal muscle, kidneys, brain, and red blood cells. As a result, ALT is a more specific indicator of liver inflammation than AST, as AST may be elevated also in diseases affecting other organs, such as myocardial infarction, acute pancreatitis, acute hemolytic anemia, severe burns, acute renal disease, musculoskeletal diseases, and trauma. The elevated AST level in hemorrhagic fever caused by crimean-congo hemorrhagic fever virus is associated with high mortality rate. AST was defined as a biochemical marker for the diagnosis of acute myocardial infarction in 1954. However, the use of AST for such a diagnosis is now redundant and has been superseded by the cardiac troponins. Laboratory tests should always be interpreted using the reference range from the laboratory that performed the test. Example reference ranges are shown below:
=== Opposition front bencher: 1967–70 === In 1967, Peter Walker invited Heseltine to be opposition spokesman on transport (not a Shadow Cabinet-level position, but reporting to Walker), after he had arranged a successful speaking tour of the West Country for him. Heseltine's duties included opposing Barbara Castle's 1967 Transport Bill (which eventually became the Transport Act 1968). Heseltine led opposition to the parts of the bill which nationalised small bus companies into the National Bus Company (UK) and set up Passenger transport executives (PTEs) in major urban areas. He criticised Castle for wanting to give PTEs the right to manufacture or produce anything necessary for their function, which as she pointed out was almost word-for-word identical to a clause in the Conservatives' Transport Act 1962. In 1968 Margaret Thatcher became Heseltine's boss for a year; he found her "embarrassingly rude". Unusually for the time, he employed a full-time researcher, Eileen Strathnaver. Heath allowed his shadow ministers more leeway than would be normal nowadays. Heseltine was one of a group of 15 Conservative MPs to vote against the 1968 Commonwealth Immigration Bill on second reading (Conservative whips advised their MPs to support it, but it was a free vote). He also voted against the bill on three subsequent votes, arguing that it was based on "sheer naked racialism" and that Britain should honour promises previously made to the Kenyan Asians.
Sources: en.wikipedia.org
=== Reactions === Crisis services for the LGBTQ+ community saw a sharp increase in usage during the election week. The Trevor Project's crisis lines saw a 125% increase since around midnight on election night according to a statement by CEO Jaymes Black on November 6, and followed an about 200% increase in election related conversations that had been seen November 3–4. By November 8, it was reported that the organization saw an overall increase by 700%. The Crisis Text Line also reported that 56% of their users reported as LGBTQ+ on election day. A company that assists wealthy Americans in securing foreign citizenship saw a 200× jump in inquiries following the election.
==== Minoxidil ==== Minoxidil, applied topically, is widely used for the treatment of hair loss. It may be effective in helping promote hair growth in both men and women with androgenic alopecia. About 40% of men experience hair regrowth after 3–6 months. It is the only topical product that is FDA approved in America for androgenic hair loss. However, increased hair loss has been reported.
S: Skin. The skin of the scalp contains numerous hair follicles and sebaceous glands. C: Connective tissue. A dense subcutaneous layer of fat and fibrous tissue that lies beneath the skin, containing the nerves and vessels of the scalp. A: Aponeurosis. The epicranial aponeurosis or galea aponeurotica is a tough layer of dense fibrous tissue which anchors the above layers in place. It runs from the frontalis muscle anteriorly to the occipitalis posteriorly. L: Loose areolar connective tissue. This layer has a gel-like consistency, and allows the more superficial layers of the scalp to shift about in relation to the pericranium. It is constituted of more matrix than fibers. It contains random collagen I bundles, collagen III and is rich in glycosaminoglycans (GAGs). In craniofacial surgery and neurosurgery this layer provides an easy plane of separation between the upper three layers and the pericranium. In scalping the scalp is also torn off through this layer. The layer is sometimes referred to as the "danger zone" because infectious agents can easily spread through it to emissary veins which drain into the cranium. P: Pericranium. This is the periosteum of the skull bones, a membrane that provides nutrition to the bone and the capacity for repair. During surgery it can be lifted from the bone to allow the removal of windows of bone (craniotomy).
Sources: en.wikipedia.org
=== 2.1b === VESA announced version 2.1b of the DisplayPort standard on 6 January 2025. It has been released in Spring 2025. DisplayPort 2.1b introduced the DP80LL ("low loss") active-cable specification, which supports four-lane UHBR20 operation at 80 Gbit/s over cables up to 3 metres long. VESA stated that this extends UHBR20 cable reach by up to three times compared with existing VESA-certified passive DP80 cables.
drugs that also prolong the QT interval because of potential problems with the heart rhythm ergot alkaloids statins triazolam and oral midazolam sulfonamides with a potential to cause hypoglycaemia (low blood sugar)
=== Blood plasma and serum === In addition to purified proteins, DSC has been applied to unfractionated blood plasma and serum; the diluted fluid is measured directly, without labeling. The resulting curve, called a thermogram, approximates the sum of the combined denaturation profiles of the most abundant plasma proteins, weighted by their concentrations. Because these proteins interact, the additivity is not exact. For plasma from healthy donors scanned at 1 °C per minute, three independant research groups reported a fibrinogen transition at about 51 °C, a dominant albumin peak near 62–63 °C, immunoglobulin and other globulin transitions between roughly 68 and 75 °C, and a weak transferrin transition at about 85 °C. Serum exhibits a similar profile, except that the fibrinogen transitions are absent. Calorimetric measurements of serum and plasma from cancer patients were documented as early as the 1990s by a team in Tbilisi, who observed broadened heat-absorption curves shifted toward higher temperatures compared to healthy controls. From 2007, Chaires, Garbett and colleagues at the University of Louisville reported that plasma from healthy individuals gave a characteristic, reproducible thermogram. Samples from patients with cervical cancer, Lyme disease, rheumatoid arthritis or systemic lupus erythematosus displayed altered profiles.
== Effects on global climate == In climate change science, ENSO is known as one of the internal climate variability phenomena. The other two main ones are Pacific decadal oscillation and Atlantic multidecadal oscillation. La Niña impacts the global climate and disrupts normal weather patterns, which can lead to intense storms in some places and droughts in others. El Niño events cause short-term (approximately 1 year in length) spikes in global average surface temperature while La Niña events cause short term cooling. Therefore, the relative frequency of El Niño compared to La Niña events can affect global temperature trends on decadal timescales.
Sources: en.wikipedia.org
Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.
The label was first attached to the albumin-binding form during early development work. A shorter analog without the linker later became known by the same name in informal use. Published papers normally state which version was studied, so the methods section resolves the ambiguity.
It is a synthetic peptide rather than a steroid, and it does not occur naturally in the body. Its sequence is derived from a hypothalamic hormone called growth hormone-releasing hormone. It works as a receptor agonist rather than as a replacement for that hormone.
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.